Authors

Guilherme Rabinowits, Miami Cancer InstituteFollow

Cemiplimab Improves Health-Related Quality of Life (HRQoL) and Reduces Pain in Patients with Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Results from a Post Hoc Exploratory Analysis of a Phase 2 Clinical Trial

Publication Date

10-2020

Presented At:

WC21 Clinical Dermatology Conference®: Skin Cancer

Content Type

Poster

Publisher's Site:

View at Publisher Website

Additional Authors:

Additional authors and institutional affiliations

Comments

This work is licensed under a Creative Commons Attribution 4.0 International License.

Citation

Rabinowits, Guilherme, "Cemiplimab Improves Health-Related Quality of Life (HRQoL) and Reduces Pain in Patients with Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Results from a Post Hoc Exploratory Analysis of a Phase 2 Clinical Trial" (2020). All Publications. 3879.
https://scholarlycommons.baptisthealth.net/se-all-publications/3879